Eisai Inc

FDA Regulatory Profile

Eisai Inc appears in FDA public data with 1 recall, 0 510(k) clearances, 17 FDA inspections, and 1 compliance action on record. Its most recent recall (D-0302-2015, Class III) was initiated on December 5, 2014.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
17
Compliance Actions
1

Known Names

eisai, eisai co, eisai company

Recent Recalls

NumberClassProductDate
D-0302-2015Class IIIBELVIQ¿ (Lorcaserin HCl) Tablets, 10 mg, 60-count bottle, Rx only, Manufactured by: Arena PharmaceutDecember 5, 2014